News
Treatment: Viral Fitness
4+ day, 22+ hour ago (115+ words) HIV can develop mutations that confer resistance to lenacapavir, but doing so comes at a cost to viral fitness. March 30, 2026 " By Liz Highleyman Email updates from POZ POZ Poll: Pharmaceutical wholesalers were recently sentenced for selling black-market HIV drugs. Do…...
Immune Checkpoint Inhibitors for People With HIV
4+ day, 21+ hour ago (236+ words) Immune Checkpoint Inhibitors for People With HIV New studies add to the evidence that immune checkpoint inhibitors are safe and effective for people with HIV and cancer. March 30, 2026 " By Liz Highleyman New studies add to the evidence that immune checkpoint…...
Immune Modulator Anktiva Does Not Control HIV Rebound
3+ week, 4+ day ago (709+ words) Immune Modulator Anktiva Does Not Control HIV Rebound HIV virus particles (purple) budding and replicating from an H9 T cell (green) NIAID The drug did have an effect on the viral reservoir and immune responses, suggesting it might play a role…...
Broadly Neutralizing Antibody Helps Maintains Viral Suppression
1+ mon, 4+ hour ago (390+ words) People who received lotivibart, a specialized antibody, with long-acting cabotegravir kept HIV under control for at least a year. March 3, 2026 " By Liz Highleyman A broadly neutralizing antibody from ViiV Healthcare, now named lotivibart, could potentially be paired with cabotegravir injections…...
Dual Immunotherapy Delays—but Does Not Prevent—HIV Rebound
1+ mon, 1+ week ago (179+ words) PD-1 immune checkpoint inhibitors are among the many approaches being studied in HIV cure research. February 25, 2026 " By Liz Highleyman At the2023 European AIDS Conference, researchers reported that the experimental PD-1 inhibitor budigalimab was associated with delayed HIV rebound or sustained low…...
When On-Target Misses the Mark: Lessons from HIV Immunogens
1+ mon, 1+ week ago (957+ words) When On-Target Misses the Mark: Lessons from HIV Immunogens It's been especially difficult to make HIV neutralizing antibodies via vaccination. February 23, 2026 " By Hannah Lewis and Fred Hutch Cancer Center Despite 40 years of intense research, the'urgently-needed'vaccine for HIV still eludes us....
Checkpoint Inhibitors Work Well for HIV-Positive People With Cancer
1+ mon, 1+ week ago (42+ words) Checkpoint Inhibitors Work Well for HIV-Positive People With Cancer'poz.com Checkpoint Inhibitors Work Well for HIV-Positive People With Cancer Checkpoint immunotherapy is a breakthrough in cancer treatment'and it may also promote HIV remission. February 23, 2026 " By Liz Highleyman...
Solving Long COVID: How Decades of HIV Research Paved the Way
2+ mon, 1+ week ago (1053+ words) Solving Long COVID: How Decades of HIV Research Paved the Way (Sars-COV-2 and HIV) istock UCSF's rapid shift to uncover the virus's hidden effects and seemingly unconnected symptoms put it at the forefront of the field. January 26, 2026 " By Victoria Colliver…...
New Clues to Understanding HIV-Related Cognitive Impairment
2+ mon, 2+ week ago (359+ words) Even when antiretroviral therapy suppresses the virus to undetectable levels in the blood, HIV can persist in the brain. January 20, 2026 " By Weill Cornell Medicine Using participant skin cells reprogrammed into neurons, Weill Cornell Medicine researchers have identified genetic signatures associated…...
HIV Research Has Led to Advances for Multiple Diseases - POZ
2+ mon, 4+ week ago (197+ words) HIV Research Has Led to Advances for Multiple Diseases January 5, 2026 " By Liz Highleyman At a time when federally funded HIV research is under threat, a group of leading experts has highlighted how HIV science over the past 40 years has not…...